iANTHUS CAPITAL HOLDINGS (ITHUF) Amortization of Deferred Charges (2020 - 2023)

iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Amortization of Deferred Charges came in at -$7.6 million in Q3 2023, down 153.24% year-on-year from $14.3 million in Q3 2022, and down 200.0% quarter-over-quarter from $7.6 million in Q2 2023.

iANTHUS CAPITAL HOLDINGS (ITHUF) Amortization of Deferred Charges (2020 - 2023) Analysis & Trends

iANTHUS CAPITAL HOLDINGS has disclosed Amortization of Deferred Charges across 4 years of filings, most recently posting -$7.6 million for Q3 2023.

  • Amortization of Deferred Charges for Q3 2023 came in at -$7.6 million, down 153.24% year-over-year; the trailing twelve-month figure through Sep 2023 was -$14.3 million (down 1957.1% YoY), and the FY2022 annual result was $804000.0, down 52.06% from the prior year.
  • Amortization of Deferred Charges came in at -$7.6 million for Q3 2023 at iANTHUS CAPITAL HOLDINGS, down from $7.6 million in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $14.3 million in Q3 2022 to a low of -$15.8 million in Q4 2021.
  • The 4-year median for Amortization of Deferred Charges is $5.1 million (2020), against an average of $1.2 million.
  • Across the five-year window, Amortization of Deferred Charges tumbled 1078.5% in 2021 and surged 249.98% in 2023, its largest moves.
  • iANTHUS CAPITAL HOLDINGS's Amortization of Deferred Charges stood at -$1.3 million in 2020, then sank by 1078.5% to -$15.8 million in 2021, then grew by 9.48% to -$14.3 million in 2022, then jumped by 46.76% to -$7.6 million in 2023.
  • The last three Amortization of Deferred Charges figures came in at -$7.6 million (Q3 2023), $7.6 million (Q2 2023), and -$14.3 million (Q4 2022), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 iANTHUS CAPITAL HOLDINGS - - 15.92 Mn

Historic Data

Download Data
DateValue
Sep 30, 2023 -7.63 Mn
Sep 30, 2023 -7.63 Mn
Jun 30, 2023 7.63 Mn
Jun 30, 2023 7.63 Mn
Dec 31, 2022 -14.34 Mn
Dec 31, 2022 -14.34 Mn
Sep 30, 2022 14.34 Mn
Sep 30, 2022 14.34 Mn
Jun 30, 2022 -5.09 Mn
Jun 30, 2022 -5.09 Mn
Mar 31, 2022 5.89 Mn
Mar 31, 2022 5.89 Mn
Dec 31, 2021 -15.84 Mn
Dec 31, 2021 -15.84 Mn
Sep 30, 2021 5.96 Mn
Sep 30, 2021 5.96 Mn
Jun 30, 2021 5.88 Mn
Jun 30, 2021 5.88 Mn
Mar 31, 2021 5.68 Mn
Mar 31, 2021 5.68 Mn